Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013-Reference-Cited by-同舟云学术

Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

Published:2013-04 Issue:4 Volume:88 Page:360-376
ISSN:0025-6196
Container-title:Mayo Clinic Proceedings
language:en
Short-container-title:Mayo Clinic Proceedings

Author:

Mikhael Joseph R.,Dingli David,Roy Vivek,Reeder Craig B.,Buadi Francis K.,Hayman Suzanne R.,Dispenzieri Angela,Fonseca Rafael,Sher Taimur,Kyle Robert A.,Lin Yi,Russell Stephen J.,Kumar Shaji,Bergsagel P. Leif,Zeldenrust Steven R.,Leung Nelson,Drake Matthew T.,Kapoor Prashant,Ansell Stephen M.,Witzig Thomas E.,Lust John A.,Dalton Robert J.,Gertz Morie A.,Stewart Keith,Rajkumar S. Vincent,Chanan-Khan Asher,Lacy Martha Q.

Publisher

Elsevier BV

Subject

General Medicine

Reference108 articles.

1. Cancer statistics 2012;Siegel;CA Cancer J Clin,2012

2. Multiple myeloma;Kyle;Blood,2008

3. Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States;Landgren;Blood,2006

4. A long-term study of prognosis in monoclonal gammopathy of undetermined significance;Kyle;N Engl J Med,2002

5. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma;Kyle;N Engl J Med,2007

Cited by 432 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chromosome 1q21 Aberrations Are Poor Prognostic Factors for Newly Diagnosed Multiple Myeloma Patients;Journal of Clinical Laboratory Analysis;2024-09-12

2. Maintenance therapy for cytogenetically high-risk multiple myeloma: landscape in the era of novel drugs;Clinical and Experimental Medicine;2024-08-06

3. ST2825, independent of MyD88, induces reactive oxygen species-dependent apoptosis in multiple myeloma cells;Biochemistry and Biophysics Reports;2024-07

4. The frequency and clinical outcome of mono-hit and multi-hit TP53 aberrations in newly diagnosed multiple myeloma;Pathology;2024-06

5. Multiple Myeloma: A Review of the Literature and a Case Report Highlighting the Immunocompromised State of Myeloma Patients;World Journal of Oncology;2024-06